Back to the MMA Newsfeed

T.J. Dillashaw explains what ‘USADA’s weapon’ is after failed UFC drug tests

T.J. Dillashaw faced a stiff penalty for his use of performance-enhancing drugs and he believes the punishment will leave a lasting legacy in MMA.

This Saturday at UFC Vegas 31, Dillashaw headlines opposite fellow bantamweight contender Cory Sandhagen. It will be the first fight since January 2019 for the two-time UFC champion, a result of Dillashaw receiving a two-year suspension from USADA after he tested positive for recombinant human erythropoietin (EPO).

Following his initial positive test, Dillashaw released a statement in April 2019 addressing his failed drug screening in which he stated simply, “I messed up.